BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31395503)

  • 1. Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study.
    Sun C; Tian X; Liu Z; Li W; Li P; Chen J; Zhang W; Fang Z; Du P; Duan H; Liu P; Wang L; Chen C; Tian J
    EBioMedicine; 2019 Aug; 46():160-169. PubMed ID: 31395503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
    Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
    Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
    Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
    Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
    J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An MRI-based machine learning radiomics can predict short-term response to neoadjuvant chemotherapy in patients with cervical squamous cell carcinoma: A multicenter study.
    Xin Z; Yan W; Feng Y; Yunzhi L; Zhang Y; Wang D; Chen W; Peng J; Guo C; Chen Z; Wang X; Zhu J; Lei J
    Cancer Med; 2023 Oct; 12(19):19383-19393. PubMed ID: 37772478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Texture analysis versus conventional MRI prognostic factors in predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced cancer of the uterine cervix.
    Ciolina M; Vinci V; Villani L; Gigli S; Saldari M; Panici PB; Perniola G; Laghi A; Catalano C; Manganaro L
    Radiol Med; 2019 Oct; 124(10):955-964. PubMed ID: 31254220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic T1 Perfusion magnetic resonance imaging evaluation of the therapeutic effect of neoadjuvant chemotherapy in locally advanced cervical cancer.
    Fu C; Feng X; Bian D; Du W; Wang X; Zhao Y
    Int J Gynecol Cancer; 2013 Sep; 23(7):1270-8. PubMed ID: 23970155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study.
    Liu Z; Li Z; Qu J; Zhang R; Zhou X; Li L; Sun K; Tang Z; Jiang H; Li H; Xiong Q; Ding Y; Zhao X; Wang K; Liu Z; Tian J
    Clin Cancer Res; 2019 Jun; 25(12):3538-3547. PubMed ID: 30842125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
    Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
    Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease.
    Li J; Ning NY; Rao QX; Chen R; Wang LJ; Lin ZQ
    BMC Cancer; 2017 Aug; 17(1):517. PubMed ID: 28774279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy.
    Arezzo F; Cormio G; Mongelli M; Cazzato G; Silvestris E; Kardhashi A; Cazzolla A; Lombardi C; Venerito V; Loizzi V
    Arch Gynecol Obstet; 2023 Jun; 307(6):1911-1919. PubMed ID: 36370209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Peng W; Wan L; Wang S; Zou S; Zhao X; Zhang H
    Front Oncol; 2023; 13():1234619. PubMed ID: 37664046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
    Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
    Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
    Liu Y; Dong TF; Li PJ; Chen LB; Song T
    Magn Reson Imaging; 2024 Jul; 110():170-175. PubMed ID: 38035947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.
    Wagner-Larsen KS; Hodneland E; Fasmer KE; Lura N; Woie K; Bertelsen BI; Salvesen Ø; Halle MK; Smit N; Krakstad C; Haldorsen IS
    Cancer Med; 2023 Oct; 12(20):20251-20265. PubMed ID: 37840437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.
    Wu MF; Guan MM; Liu CH; Wu JY; Rao QX; Li J
    Cancer Med; 2019 Sep; 8(11):5068-5078. PubMed ID: 31310455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI.
    Yardimci AH; Kocak B; Sel I; Bulut H; Bektas CT; Cin M; Dursun N; Bektas H; Mermut O; Yardimci VH; Kilickesmez O
    Jpn J Radiol; 2023 Jan; 41(1):71-82. PubMed ID: 35962933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of 2D/3D Ultrasound to Assess the Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
    Perniola G; Tomao F; Graziano M; Palaia I; Fischetti M; Lecce F; Casorelli A; Di Donato V; Giancotti A; Battaglia FA; Muzii L; Benedetti Panici P
    Oncology; 2020; 98(11):807-813. PubMed ID: 32892198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.